Lucas Borges Pereira

Lucas Borges Pereira

Auto-generated profile, based on publicly available information

Lucas Borges Pereira

Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Revista da Sociedade Brasileira de Medicina Tropical
Verified
Journal Article
Open access
LPLucas Borges Pereira
Lucas Borges Pereira
MZMaria Olívia Barboza Zanetti
Maria Olívia Barboza Zanetti
LSLarissa Pombeiro Sponchiado
Larissa Pombeiro Sponchiado
JRJoão Paulo Vilela Rodrigues
João Paulo Vilela Rodrigues
MCMarília Silveira de Almeida Campos
Marília Silveira de Almeida Campos
LPLeonardo Pereira
Leonardo Pereira
This systematic review aimed to assess antibiotic use in Brazilian hospitals in the 21st century, as well as to understand the different drug utilization metrics adopted to assess the consumption of these drugs. We systematically reviewed five databases (MEDLINE [Medical Literature Analysis and Retrieval System Online], CENTRAL [The Cochrane Central Register of Controlled Trials], EMBASE® [Excerpta Medica Database], Scopus [Elsevier's abstract and citation database], and LILACS [Literatura Latino-Americana e do Caribe em Ciências da Saúde]) for observational or experimental studies that assessed antibiotic utilization in Brazilian hospitals. The main outcomes were the drug utilization metrics and the consumption of antibiotics. We included 23 studies, of which 43.5% were carried out in adult and pediatric care units, 39.1% in adult units, and 17.4% in pediatric units. Regarding the complexity of healthcare, 26.1% of the studies were performed in intensive care units. Two drug utilization metrics were used in these studies: the defined daily dose (DDD) and the percentage of antibiotic prescriptions. The most commonly used antibiotic classes were third-generation cephalosporins, carbapenems, fluoroquinolones, and combinations of penicillins when the DDD was the adopted drug utilization metric. Although few studies have been conducted, existing data indicate a high use of broad-spectrum antibiotics. We found that the lack of standardized antibiotic utilization metrics impaired the mapping of drug consumption at the national level.

12 November 2020 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
LPLucas Borges Pereira
Lucas Borges Pereira
CFCinara Silva Feliciano
Cinara Silva Feliciano
DSDiego Silva Siqueira
Diego Silva Siqueira
FBFernando Bellissimo-Rodrigues
Fernando Bellissimo-Rodrigues
LPLeonardo Pereira
Leonardo Pereira
Objective: To assess the surgical antibiotic prophylaxis. Methods: This was a descriptive study performed at a public tertiary care university hospital gathering prescription, sociodemographic and hospitalization data of inpatients admitted in 2014 who used antimicrobial drugs. This data were obtained from the hospital electronic database. The antimicrobial data were classified according to the anatomical, therapeutic chemical/defined daily dose per 1,000 inpatients. An exploratory analysis was performed using principal component analysis. Results: A total of 5,182 inpatients were prescribed surgical [...] ABSTRACT Objective: To assess the surgical antibiotic prophylaxis. Methods: This was a descriptive study performed at a public tertiary care university hospital gathering prescription, sociodemographic and hospitalization data of inpatients admitted in 2014 who used antimicrobial drugs. This data were obtained from the hospital electronic database. The antimicrobial data were classified according to the anatomical, therapeutic chemical/defined daily dose per 1,000 inpatients. An exploratory analysis was performed using principal component analysis. Results: A total of 5,182 inpatients were prescribed surgical

20 February 2020 in SMAD, Revista Eletrônica Saúde Mental Álcool e Drogas (Edição em Português)
Verified
Journal Article
Open access
PDF file
SASamir Antonio Rodrigues Abjaude
Samir Antonio Rodrigues Abjaude
LPLucas Borges Pereira
Lucas Borges Pereira
MZMaria Olívia Barboza Zanetti
Maria Olívia Barboza Zanetti
LPLeonardo Pereira
Leonardo Pereira

10 July 2024 in American Journal of Infection Control
Verified
Journal Article
Closed access
LPLucas Borges Pereira
Lucas Borges Pereira
CFCinara Silva Feliciano
Cinara Silva Feliciano
FBFernando Bellissimo-Rodrigues
Fernando Bellissimo-Rodrigues
LPLeonardo Régis Leira Pereira
Leonardo Régis Leira Pereira

6 August 2020 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
LPLucas Borges Pereira
Lucas Borges Pereira
AGAna Maria Rosa Freato Gonçalves
Ana Maria Rosa Freato Gonçalves
CFCamila Stéfani Estancial Fernandes
Camila Stéfani Estancial Fernandes
AFAndréia Turmina Fontanella
Andréia Turmina Fontanella
PFPriscila Maria Stolses Bergamo Francisco
Priscila Maria Stolses Bergamo Francisco
KCKaren Sarmento Costa
Karen Sarmento Costa
Objective To estimate the prevalence of use of drugs to treat gastrointestinal disorders, according to demographic, socioeconomic, and health characteristics of the Brazilian population. Methods This is a population-based survey that interviewed individuals residing in cities of the five regions in Brazil. The study sample was composed of 32,348 individuals aged 20 or more years. The profile of use of drugs for gastrointestinal disorders was evaluated considering the variables sex, age, healthcare plan, region, and number of chronic diseases. [...] ABSTRACT Objective To estimate the prevalence of use of drugs to treat gastrointestinal disorders, according to demographic, socioeconomic, and health characteristics of the Brazilian population. Methods This is a population-based survey that interviewed individuals residing in cities of the five regions in Brazil. The study sample was composed of 32,348 individuals aged 20 or more years. The profile of use of drugs for gastrointestinal disorders was evaluated considering the variables sex, age, healthcare plan, region, and number of chronic diseases.

1 September 2023 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
LPLucas Borges Pereira
Lucas Borges Pereira
JRJoão Paulo Vilela Rodrigues
João Paulo Vilela Rodrigues
FVFabiana Rossi Varallo
Fabiana Rossi Varallo
LPLeonardo Régis Leira Pereira
Leonardo Régis Leira Pereira
A Síndrome Pós-Covid-19 foi definida pela Organização Mundial da Saúde como uma “condição que ocorre em indivíduos com histórico de infecção provável ou confirmada por SARS-CoV-2, normalmente após três meses do início da Covid-19, com sintomas que duram pelo menos dois meses e que um diagnóstico alternativo não pode explicar”. Os principais sintomas associados a esta condição incluem fadiga, dores musculares e articulares, falta de ar, dificuldades de sono, sintomas mentais e neurológicos como depressão e ansiedade, perda de olfato